ONYX PHARMACEUTICALS, INC.
Exhibit 11.1
COMPUTATION OF NET LOSS PER SHARE
(In thousands, except per share amounts)
(unaudited)
Three Months Ended Six Months Ended
June 30, June 30,
-------------------- --------------------
1997 1996 1997 1996
--------- --------- --------- ---------
NET LOSS: $ (3,758) $ (2,367) $ (6,251) $ (4,660)
--------- --------- --------- ---------
--------- --------- --------- ---------
Shares used in net loss per share computation:
Weighted average shares of common stock
outstanding: 9,680 5,814 9,602 3,395
Shares related to Staff Accounting
Bulletins Nos. 55, 64 and 83 - - - 213
--------- --------- --------- ---------
Shares used in net loss per share
computation: 9,680 5,814 9,602 3,608
--------- --------- --------- ---------
--------- --------- --------- ---------
Net loss per share $ (0.39) $ (0.41) $ (0.65) $ (1.29)
--------- --------- --------- ---------
--------- --------- --------- ---------
CALCULATION OF SHARES OUTSTANDING FOR
COMPUTING PRO FORMA NET LOSS PER SHARE:
Shares used in computing historical net
loss per share (from above): 5,814 3,608
Adjusted to reflect the effect of the assumed
conversion of convertible preferred stock from
the date of issuance: 2,260 3,750
--------- ---------
Shares used in computing pro forma net loss
per share: 8,074 7,358
--------- ---------
--------- ---------
Pro forma net loss per share $ (0.29) $ (0.63)
--------- ---------
--------- ---------